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Transplantation (BMT). A new BMT unit was designed as a
specialized closed unit culminating an open living space in a
state of the art family-centered care environment for patients
who are severely immunocompromised. The unit maintains
fourteen single patient rooms with vertical anterooms be-
tween rooms for routine patient access. There is a family rest/
storage area, six nurses’ stations, medication, utility and
supply/equipment rooms and other support areas on the unit.
There is one central monitoring station near unit entry.
Nurses’ stations were designed adjacent to the patient rooms,
minimizing walking distances for nursing and maximizing
views of all patient rooms. Within one year post move in,
patient volumes and acuity steadily increased and an array of
nursing workﬂow challenges presented themselves. These
issues were related to delivery and administration of medi-
cations inclusive of new intravenous (IV) volumetric pumps,
geographical distance causing alteration in communication,
nursing physical ailments and a decrease in patient family
survey responses to nurses’ responding to patient needs/
requests.
Methods, Intervention, & Analysis: In attempt to mitigate
these challenges, senior BMT and intensive care staff iden-
tiﬁed key indicators for workﬂow assessments. Six twelve
hour shift observational workﬂow studies were completed
by BMT and non BMT staff for day and night shifts equally.
This presentation will detail the study results.
Findings & Interpretation: Results provided justiﬁcation to
increase patient hours of care, increase nurse FTEs, install
automatic patient room door openers, purchase beds/cribs
with built in scales, install additional central monitors,
replace patient room blinds for improved visualization,
revise IV supplies and medication administration procedures
and plan for a pharmacy concierge service.
Discussion & Implications: It is imperative that nursing is
frontline in the initial and ongoing stages of planning and
design for new specialized environmental patient care units.480
Infection prevention in BMT patient’s utilizing
chlorhexidine bathing
Lesley Hooser, Susan Launder, Noel Arring. Mayo Clinic,
Phoenix, Arizona
Topic Signiﬁcance & Study Purpose/Background/Rationale:
The blood and marrow transplant (BMT) patients are at high
risk for central line associated blood stream infections (Clabsi)
as well as clostridium difﬁcile (c-diff) related to their treat-
ments and immunosuppressive states. A literature searchwas
completed related to the possible use of chlorhexidine (CHG)
to bathe the patients; the manufacturer guidelines were also
referenced on the optimal way to institute the bathing. The
predictionwas that by instituting CHG daily bathing the rates
of Clabsi and c-diff may be impacted and decrease.
Methods, Intervention, & Analysis: Education was initiated
in June for the registered nurses (RN) and the patient care
assistants (PCA), utilizing posters, daily reminders, and
weekly newsletter reminders. Patient education was also
initiated, in the form of a leaﬂet with the procedure of
showering with CHG; this was provided to patients on
admission. The launch of CHG showering was July 1st (the
beginning of the 3rd quarter reporting). Follow up education
was completed with the RN’s and the PCA’s in October. The
PCA’s received amore extensive breakdown of the beneﬁts of
CHG bathing in relation to methicillin resistant staphylo-
coccus aureus, vancomycin resistant enterococcus and clos-
tridium difﬁcile.Findings & Interpretation: Two months after the imple-
mentation of the CHG showering an audit was completed to
gauge the percentage of patients that where bathed with
CHG, the BMT patients were bathed 82% of the time with
CHG. The 3rd quarter clabsi and c diff initial results, although
not yet conﬁrmed, are favorable in regards to reduced rates
of clabsi and c-diff.
Discussion & Implications: The CHG showering/bathing is
an added advantage to the interventions used to try and
reduce Clabsi and c-diff infections, we will continue with
the CHG showering and bathing as well as monitor the
results.481
Safety and Efﬁciency of Administering Foscarnet in an
Intensive Adult Bone Marrow Transplant Clinic: A
Multidisciplinary Approach
Sheila Kenny, Lorraine Jackson, Gloria Coffey, Anne A. Eaton,
Sergio Giralt, Juliet N. Barker, Stephen Harnicar. Memorial
Sloan-Kettering Cancer Center, New York, New York
Topic Signiﬁcance & Study Purpose/Background/Rationale:
Allogeneic hematopoietic stem cell transplant (HSCT) pa-
tients frequently reactivate cytomegalovirus (CMV) and
human herpes virus type 6 (HHV-6). Administration of the
antiviral foscarnet is efﬁcacious therapy in many patients.
Foscarnet administration, however, is complex given the need
for dose modiﬁcations based on renal function and the
considerable risk of nephrotoxicity and serious electrolyte
abnormalities. This requirement, along with increases in
patient volume, mandates an efﬁcient standard operating
procedure (SOP) to facilitate safe foscarnet administration in
the outpatient setting. The purpose of this multidisciplinary
studywas to compare three SOPs for foscarnet administration
for efﬁciency (patient clinic time and amount of calcium
repletion) and toxicity (electrolyte, renal and neurologic).
Methods, Intervention, & Analysis: In this IRB approved
study, data were collected on HSCT patients to evaluate 3
SOPs for foscarnet administration: SOP1 (Apr-June 2012),
SOP2 (Jun-Sept 2012) and SOP3 (Jan-May 2013) (Figure 1).
Foscarnet was administered with high volume hydration.
Data analyzed included foscarnet dose (mg/kg), ionized cal-
cium (iCa) and magnesium (Mg) levels, creatinine clearance
(CrCl), dose of intravenous calcium repletion, neurological
symptoms of hypocalcemia and length of clinic visits.
Continuous outcomes were summarized using means and
standard deviations. Differences between SOPs were tested
using a GEE linear model that accounted for patient-level
correlation.
Findings & Interpretation: There were 52, 33 and 85 fos-
carnet visits which corresponded to 4, 4 and 8 patients for
SOPs 1, 2 and 3, respectively. Patients were treated for CMV
or HHV6 viremia. No patient had symptomatic hypocalce-
mia. SOPs were comparable with respect to Mg level and
nephrotoxicity, but SOP 3 had a signiﬁcantly higher mean
pre-foscarnet iCa level of 5.1 mg/dL than SOP1 (4.8 mg/dL) (p
¼ 0.02). SOP2 was associated with a higher mean calcium
repletion/visit of 6 gm than SOPs 1 (4 gm) or 3 (4 gm) (p ¼
0.05). Finally, the shortest mean patient clinic time was with
SOP3 (271 minutes) compared with SOPs 1 (396 minutes) or
2 (388 minutes) (p ¼ 0.03, Figure 2).
Discussion & Implications: This analysis shows that sub-
stitution of a post-foscarnet iCa measurement with empiric
post-foscarnet calcium repletion (SOP3) is more efﬁcient by
decreasing total amount of calcium repletion and patient
clinic time without compromising safety.
